LC-MS/MS-based phytochemical profiling and preliminary in vitro anticancer-related bioactivity of Euphorbia petrophila ethanol extract.
5 affiliations
- 1İnönü University Vocational School of Health Services, Malatya, Turkey. [email protected].
- 2Department of Molecular Biology and Genetics, Inonu University, Malatya, Turkey.
- 3İnönü University Vocational School of Health Services, Malatya, Turkey.
- 4Department of Medical Biology and Genetics, Faculty of Medicine, Inonu University, Malatya, Turkey.
- 5Department of Biology, Faculty of Arts and Sciences, Inonu University, Division of Botany, Malatya, Turkey.
Abstract
Background
Euphorbia species contain diverse secondary metabolites with reported biological activities, but Euphorbia petrophila remains pharmacologically underexplored. This study aimed to characterize the phytochemical profile of E. petrophila ethanol extract and evaluate its preliminary in vitro anticancer-related activity in lung and breast cancer cell models.Methods
Aerial parts of E. petrophila were extracted with ethanol using ultrasonic-assisted extraction. The extract was profiled by LC-MS/MS. Cytotoxicity was assessed by MTT assay in A549 and MDA-MB-231 cancer cells and in BEAS-2B and MCF10A non-tumorigenic epithelial cells. Apoptosis and cell-cycle distribution were analyzed by flow cytometry. Migration and invasion were evaluated using Transwell assays, and selected gene-expression changes were measured by RT-qPCR. Data were analyzed using appropriate analysis of variance and post hoc comparisons.Results
LC-MS/MS analysis identified phenolic acids and flavonoids, with gallic acid, quinic acid, ellagic acid, and isoquercitrin among the most abundant detected constituents. The extract reduced IC₅₀ value of in all tested cell lines, with the strongest cytotoxic effect observed in A549 cells. It increased apoptotic cell populations and promoted G0/G1 cell-cycle accumulation, particularly in A549 cells. The extract also markedly suppressed migration and invasion in A549 and MDA-MB-231 cells. These functional effects were accompanied by changes in TP53 and CDKN1A mRNA expression.Conclusions
E. petrophila ethanol extract shows preliminary antiproliferative, pro-apoptotic, anti-migratory, and anti-invasive activity in selected cancer cell models. However, because the findings are based on crude extract testing and transcript-level analyses, the results should be interpreted as preliminary and correlative. Further work should include extract standardization, LC-MS/MS method validation, broader normal-cell toxicity profiling, active-compound isolation, protein-level mechanistic assays, and in vivo safety and efficacy studies.
Related
- Phytochemical Profiling and Anticancer Potential of Ipomoea hederifolia L. Root Extract: LC-MS Characterization and Molecular Docking Insights.
- Alkaloids Reported in the Genus Griffinia (Amaryllidaceae): Phytochemical Evidence and Current Limitations in Anticancer Interpretation
- Organ-Differentiated Metabolomic Profiling Reveals Putative Associations Between Predicted Bioactivity and Database-Annotated Flavor in Medicinal–Edible Talinum paniculatum (Jacq.) Gaertn
- Phytochemical analyses, antimicrobial, antioxidant and anticancer activities of endophytic fungi from leaves of Reseda pruinosa
- Chemical profiling and multitarget computational screening reveal bioactive phytochemical scaffolds from Echiochilon pauciflorum stocks ex wight
BibTeX
@article{guzel2026lcmsmsbased,
title = {{LC-MS/MS-based phytochemical profiling and preliminary in vitro anticancer-related bioactivity of Euphorbia petrophila ethanol extract.}},
author = {Mehmet Ali Güzel and İrem Nur Menevşe and Turgay Kolaç and Şengül Yüksel and Birol Mutlu},
journal = {BMC complementary medicine and therapies},
year = {2026},
month = jul,
doi = {10.1186/s12906-026-05470-8},
url = {https://europepmc.org/article/MED/42897600},
note = {CC BY},
}
RIS
TY - JOUR
TI - LC-MS/MS-based phytochemical profiling and preliminary in vitro anticancer-related bioactivity of Euphorbia petrophila ethanol extract.
AU - Mehmet Ali Güzel
AU - İrem Nur Menevşe
AU - Turgay Kolaç
AU - Şengül Yüksel
AU - Birol Mutlu
PY - 2026
DA - 2026/07/23
JO - BMC complementary medicine and therapies
DO - 10.1186/s12906-026-05470-8
UR - https://europepmc.org/article/MED/42897600
AB - Background Euphorbia species contain diverse secondary metabolites with reported biological activities, but Euphorbia petrophila remains pharmacologically underexplored. This study aimed to characterize the phytochemical profile of E. petrophila ethanol extract and evaluate its preliminary in vitro anticancer-related activity in lung and breast cancer cell models.Methods Aerial parts of E. petrophila were extracted with ethanol using ultrasonic-assisted extraction. The extract was profiled by LC-MS/MS. Cytotoxicity was assessed by MTT assay in A549 and MDA-MB-231 cancer cells and in BEAS-2B and MCF10A non-tumorigenic epithelial cells. Apoptosis and cell-cycle distribution were analyzed by flow cytometry. Migration and invasion were evaluated using Transwell assays, and selected gene-expression changes were measured by RT-qPCR. Data were analyzed using appropriate analysis of variance and post hoc comparisons.Results LC-MS/MS analysis identified phenolic acids and flavonoids, with gallic acid, quinic acid, ellagic acid, and isoquercitrin among the most abundant detected constituents. The extract reduced IC₅₀ value of in all tested cell lines, with the strongest cytotoxic effect observed in A549 cells. It increased apoptotic cell populations and promoted G0/G1 cell-cycle accumulation, particularly in A549 cells. The extract also markedly suppressed migration and invasion in A549 and MDA-MB-231 cells. These functional effects were accompanied by changes in TP53 and CDKN1A mRNA expression.Conclusions E. petrophila ethanol extract shows preliminary antiproliferative, pro-apoptotic, anti-migratory, and anti-invasive activity in selected cancer cell models. However, because the findings are based on crude extract testing and transcript-level analyses, the results should be interpreted as preliminary and correlative. Further work should include extract standardization, LC-MS/MS method validation, broader normal-cell toxicity profiling, active-compound isolation, protein-level mechanistic assays, and in vivo safety and efficacy studies.
SN - 2662-7671
ER -